流通市值:7.67亿 | 总市值:15.29亿 | ||
流通股本:6685.25万 | 总股本:1.33亿 |
报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 287,269,148 | 388,033,709.23 | 434,093,495.23 | 424,737,681.64 |
结算备付金 | - | - | - | 0 |
拆出资金 | - | - | - | 0 |
衍生金融资产 | - | - | - | 0 |
应收票据及应收账款 | 602,213.29 | 752,348.32 | 874,507.99 | 966,918.81 |
其中:应收票据 | - | - | - | 0 |
应收账款 | 602,213.29 | 752,348.32 | 874,507.99 | 966,918.81 |
应收款项融资 | - | - | - | 0 |
预付款项 | 11,802,693.74 | 8,785,235.61 | 10,333,144.57 | 4,974,033.27 |
应收保费 | - | - | - | 0 |
应收分保账款 | - | - | - | 0 |
应收分保合同准备金 | - | - | - | 0 |
其他应收款合计 | 3,574,276.05 | 4,307,490.69 | 3,696,232.66 | 3,520,987.97 |
其中:应收利息 | - | - | - | 0 |
应收股利 | - | - | - | 0 |
买入返售金融资产 | - | - | - | 0 |
存货 | 14,596,183.25 | 10,296,362.45 | 14,426,946.84 | 14,383,463.61 |
合同资产 | - | - | - | 0 |
一年内到期的非流动资产 | - | - | - | 145,600,833.42 |
其他流动资产 | 15,720,028.9 | 17,238,042.25 | 16,876,190.26 | 16,908,228.25 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 939,375,004.56 | 938,107,704.09 | 939,510,715.02 | 1,025,240,875.41 |
非流动资产: | ||||
发放委托贷款及垫款 | - | - | - | 0 |
债权投资 | 21,091,659.63 | 20,925,757.99 | 20,760,305.93 | 20,595,757.98 |
其他债权投资 | - | - | - | 0 |
长期应收款 | - | - | - | 0 |
长期股权投资 | 564,563.09 | 470,005.77 | 573,998.31 | 563,786.51 |
其他权益工具投资 | - | - | - | 0 |
其他非流动金融资产 | 16,927,257.2 | 16,927,257.2 | 17,049,336.65 | 18,131,030.45 |
投资性房地产 | 185,030,530.2 | 195,359,181.94 | 186,166,937.76 | 186,735,141.54 |
固定资产 | 89,972,198.58 | 87,215,206.56 | 98,744,468.86 | 100,336,138.74 |
在建工程 | - | - | - | 0 |
生产性生物资产 | - | - | - | 0 |
油气资产 | - | - | - | 0 |
使用权资产 | 28,339,936.23 | 32,559,043.36 | 31,616,852.46 | 37,404,159.62 |
无形资产 | 31,107,239.58 | 31,464,184.14 | 32,462,795.19 | 33,094,739.96 |
开发支出 | - | - | - | 0 |
商誉 | - | - | - | 0 |
长期待摊费用 | 15,035,952.69 | 14,813,552.08 | 17,735,242.42 | 18,056,472.41 |
递延所得税资产 | 12,874,392.96 | 12,603,755.68 | 12,874,392.96 | 12,874,392.96 |
其他非流动资产 | 270,000 | 210,000 | 210,000 | 239,008.85 |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 401,213,730.16 | 412,547,944.72 | 418,194,330.54 | 428,030,629.02 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 1,340,588,734.72 | 1,350,655,648.81 | 1,357,705,045.56 | 1,453,271,504.43 |
流动负债: | ||||
短期借款 | - | 10,000,000 | 10,000,000 | 0 |
向中央银行借款 | - | - | - | 0 |
吸收存款及同业存放 | - | - | - | 0 |
拆入资金 | - | - | - | 0 |
交易性金融负债 | - | - | - | 0 |
衍生金融负债 | - | - | - | 0 |
应付票据及应付账款 | 40,248,771.91 | 29,085,112.5 | 20,379,206.99 | 52,700,773.25 |
其中:应付票据 | 5,016,499 | - | - | 0 |
应付账款 | 35,232,272.91 | 29,085,112.5 | 20,379,206.99 | 52,700,773.25 |
预收款项 | - | 174,363.3 | - | 10,999 |
合同负债 | 463,857,164.04 | 476,913,264.35 | 458,797,855.21 | 484,572,430.05 |
卖出回购金融资产款 | - | - | - | 0 |
应付手续费及佣金 | - | - | - | 0 |
应付职工薪酬 | 27,205,848.83 | 25,843,677.24 | 22,030,551.4 | 31,737,109.14 |
应交税费 | 8,776,287.3 | 6,764,124.62 | 6,553,107.52 | 16,656,886.78 |
其他应付款合计 | 64,746,157.14 | 68,863,007.62 | 65,944,975.52 | 85,399,113.58 |
其中:应付利息 | - | - | - | 0 |
应付股利 | - | - | - | 0 |
应付分保账款 | - | - | - | 0 |
保险合同准备金 | - | - | - | 0 |
代理买卖证券款 | - | - | - | 0 |
代理承销证券款 | - | - | - | 0 |
一年内到期的非流动负债 | 15,851,943.83 | 16,843,075.01 | 18,560,169.74 | 18,396,544.59 |
其他流动负债 | 31,062,057.8 | 32,248,153.02 | 30,917,414.12 | 32,598,621.51 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 651,748,230.85 | 666,734,777.66 | 633,183,280.5 | 722,072,477.9 |
非流动负债: | ||||
长期借款 | - | - | - | 0 |
应付债券 | - | - | - | 0 |
优先股 | - | - | - | 0 |
永续债 | - | - | - | 0 |
租赁负债 | 14,470,873.98 | 18,005,264.81 | 15,670,399.23 | 21,457,706.39 |
长期应付款 | - | - | - | 0 |
长期应付职工薪酬 | - | - | - | 0 |
预计负债 | - | - | - | 0 |
递延收益 | - | - | - | 0 |
递延所得税负债 | 10,836,739.64 | 10,850,336.4 | 10,836,739.64 | 10,836,739.64 |
其他非流动负债 | - | - | - | 0 |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 25,307,613.62 | 28,855,601.21 | 26,507,138.87 | 32,294,446.03 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 677,055,844.47 | 695,590,378.87 | 659,690,419.37 | 754,366,923.93 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 133,340,000 | 133,340,000 | 133,340,000 | 133,340,000 |
其他权益工具 | - | - | - | 0 |
优先股 | - | - | - | 0 |
永续债 | - | - | - | 0 |
资本公积 | 160,810,942.5 | 160,810,942.5 | 160,810,942.5 | 160,810,942.5 |
减:库存股 | 19,567,043 | 19,567,043 | 5,696,329 | 0 |
其他综合收益 | - | - | - | 0 |
专项储备 | - | - | - | 0 |
盈余公积 | 54,197,624.13 | 54,197,624.13 | 54,197,624.13 | 54,197,624.13 |
一般风险准备 | - | - | - | 0 |
未分配利润 | 317,540,947.23 | 310,166,164.24 | 336,687,307.23 | 333,002,961.68 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 646,322,470.86 | 638,947,687.87 | 679,339,544.86 | 681,351,528.31 |
少数股东权益 | 17,210,419.39 | 16,117,582.07 | 18,675,081.33 | 17,553,052.19 |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 663,532,890.25 | 655,065,269.94 | 698,014,626.19 | 698,904,580.5 |
负债和股东权益合计 | 1,340,588,734.72 | 1,350,655,648.81 | 1,357,705,045.56 | 1,453,271,504.43 |
公告日期 | 2024-10-25 | 2024-08-31 | 2024-04-27 | 2024-04-27 |
审计意见(境内) | 标准无保留意见 |